Helius Medical Technologies, Inc.
HSDT
$4.18
-$0.24-5.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -37.40% | -21.32% | -39.97% | -33.41% | -11.13% |
| Total Other Revenue | -2.22% | 12.82% | 51.72% | 131.58% | 542.86% |
| Total Revenue | -35.03% | -19.25% | -36.62% | -29.70% | -5.65% |
| Cost of Revenue | -0.68% | -0.17% | -19.44% | -7.00% | 26.68% |
| Gross Profit | -273.81% | -201.64% | -110.74% | -73.61% | -65.99% |
| SG&A Expenses | 16.05% | 9.14% | -0.35% | -17.45% | -15.57% |
| Depreciation & Amortization | -80.00% | -79.49% | -80.54% | -67.07% | -50.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.73% | 11.38% | 0.15% | -14.48% | -14.75% |
| Operating Income | -21.75% | -12.99% | -2.44% | 13.54% | 15.21% |
| Income Before Tax | -47.25% | -32.68% | 30.19% | 12.15% | 27.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.25% | -32.68% | 30.19% | 12.15% | 27.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.25% | -32.68% | 30.19% | 12.15% | 27.40% |
| EBIT | -21.75% | -12.99% | -2.44% | 13.54% | 15.21% |
| EBITDA | -22.63% | -14.01% | -3.37% | 12.90% | 14.69% |
| EPS Basic | 75.45% | 59.78% | 71.25% | 43.50% | 18.91% |
| Normalized Basic EPS | 75.07% | 59.17% | 70.93% | 37.75% | 8.18% |
| EPS Diluted | 75.41% | 59.75% | 71.23% | 43.48% | 18.89% |
| Normalized Diluted EPS | 75.07% | 59.17% | 70.93% | 37.75% | 8.18% |
| Average Basic Shares Outstanding | 537.11% | 332.41% | 229.94% | 130.11% | 85.84% |
| Average Diluted Shares Outstanding | 537.11% | 332.41% | 229.94% | 130.11% | 85.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |